Patrick Erbacher received his PhD from the Centre of Molecular Biophysics, CNRS, Orléans, France, on cationic polymer mediated nucleic acid delivery in 1996. He joined the Laboratory of Dr Jean-Paul Behr, CNRS & University of Strasbourg, where he developed synthetic nucleic acid delivery systems based on targeted and modified polyethylenimine-based nanoparticles. In 1999, he received the Thermo Fisher Scientific Prize for Biotherapy. He participated in Polyplus-transfection’s funding in 2001. Since then, he is managing the R&D activity. He is the co-inventor of many patent applications and co-author of more than 60 publications.